Company / Operating Income
Bausch & Lomb Corp Operating Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$113.0M
FY2025
5-year range
$113.0M / $329.0M
FY2021-FY2025
Trend
-30.2%
vs FY2024
Sector context
#66 of 151
Health Care
What the data says
At $113M, Bausch & Lomb Corp's operating income ranks #66 of 151 in the Health Care sector. Operating Income has fluctuated over the past 6 years, ranging from $113M in FY2025 to $329M in FY2021.
Based on SEC 10-K filings.
$113M in FY2025 with a 5-year CAGR of -15.4%.
Declined from $130M to $113M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -18.3%
- 5-Year CAGR
- -15.4%
- 10-Year CAGR
- -
Sector benchmark
#66 of 151 in Health CareTop 44% of 151This company $113.0M Sector average $716.7M
▼
-84.2% below sector average
Key checks
Key Insights
- 5-year CAGR of -15.4%, indicating a declining trend.
- In FY2025, operating income decreased 30.2% year-over-year.
- Ranks #66 out of 151 companies in the Health Care sector.
- Peak operating income was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $113.0M | -30.2% |
| FY2024 | $162.0M | +24.6% |
| FY2023 | $130.0M | -37.2% |
| FY2022 | $207.0M | -37.1% |
| FY2021 | $329.0M | +26.5% |
| FY2020 | $260.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026